Type 2 Diabetes As an Inflammatory Disease

Overview

Journal Nat Rev Immunol

Specialty Allergy & Immunology

Date 2011 Jan 15

PMID 21233852

Citations 1487

Authors

Marc Y Donath

Steven E Shoelson

Affiliations

Soon will be listed here.

Abstract

Components of the immune system are altered in obesity and type 2 diabetes (T2D), with the most apparent changes occurring in adipose tissue, the liver, pancreatic islets, the vasculature and circulating leukocytes. These immunological changes include altered levels of specific cytokines and chemokines, changes in the number and activation state of various leukocyte populations and increased apoptosis and tissue fibrosis. Together, these changes suggest that inflammation participates in the pathogenesis of T2D. Preliminary results from clinical trials with salicylates and interleukin-1 antagonists support this notion and have opened the door for immunomodulatory strategies for the treatment of T2D that simultaneously lower blood glucose levels and potentially reduce the severity and prevalence of the associated complications of this disease.

Citing Articles

The Role of TLRs in Obesity and Its Related Metabolic Disorders.

Campos-Bayardo T, Roman-Rojas D, Garcia-Sanchez A, Cardona-Munoz E, Sanchez-Lozano D, Totsuka-Sutto S Int J Mol Sci. 2025; 26(5).

PMID: 40076851 PMC: 11900219. DOI: 10.3390/ijms26052229.

Application of Ultrasound Localization Microscopy in Evaluating the Type 2 Diabetes Progression.

Zhang T, Yan J, Zhou X, Wu B, Zhang C, Tang M Cyborg Bionic Syst. 2025; 6:0117.

PMID: 40066372 PMC: 11893074. DOI: 10.34133/cbsystems.0117.

Echocardiographic and biomarker characteristics in diabetes, coronary artery disease or both: insights from HOMAGE trial.

Monzo L, Kobayashi M, Ferreira J, Lamiral Z, Delles C, Clark A Cardiovasc Diabetol. 2025; 24(1):111.

PMID: 40057728 PMC: 11890510. DOI: 10.1186/s12933-025-02609-8.

Exploring the glucose-lowering and anti-inflammatory immune mechanism of artemether by AMPK/mTOR pathway and microbiome based on multi-omics.

Jiang T, Du P, Liu D, Chen H, Ma Y, Hu B Front Pharmacol. 2025; 16:1520439.

PMID: 40046742 PMC: 11879814. DOI: 10.3389/fphar.2025.1520439.

Editorial: Omics in endocrinology: from biomarker discovery to targeting therapeutic strategies.

Costanzo M, Aleidi S, Abdel Rahman A Front Mol Biosci. 2025; 12:1567250.

PMID: 40017631 PMC: 11865747. DOI: 10.3389/fmolb.2025.1567250.

References

Feuerer M, Herrero L, Cipolletta D, Naaz A, Wong J, Nayer A . Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med. 2009; 15(8):930-9. PMC: 3115752. DOI: 10.1038/nm.2002. View

Boni-Schnetzler M, Thorne J, Parnaud G, Marselli L, Ehses J, Kerr-Conte J . Increased interleukin (IL)-1beta messenger ribonucleic acid expression in beta -cells of individuals with type 2 diabetes and regulation of IL-1beta in human islets by glucose and autostimulation. J Clin Endocrinol Metab. 2008; 93(10):4065-74. PMC: 2579638. DOI: 10.1210/jc.2008-0396. View

Rossetti L, Smith D, Shulman G, Papachristou D, DeFronzo R . Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats. J Clin Invest. 1987; 79(5):1510-5. PMC: 424427. DOI: 10.1172/JCI112981. View

Fourlanos S, Narendran P, Byrnes G, Colman P, Harrison L . Insulin resistance is a risk factor for progression to type 1 diabetes. Diabetologia. 2004; 47(10):1661-7. DOI: 10.1007/s00125-004-1507-3. View

Herder C, Illig T, Rathmann W, Martin S, Haastert B, Muller-Scholze S . Inflammation and type 2 diabetes: results from KORA Augsburg. Gesundheitswesen. 2005; 67 Suppl 1:S115-21. DOI: 10.1055/s-2005-858252. View

Hosogai N, Fukuhara A, Oshima K, Miyata Y, Tanaka S, Segawa K . Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes. 2007; 56(4):901-11. DOI: 10.2337/db06-0911. View

Masters S, Dunne A, Subramanian S, Hull R, Tannahill G, Sharp F . Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes. Nat Immunol. 2010; 11(10):897-904. PMC: 3103663. DOI: 10.1038/ni.1935. View

Maedler K, Oberholzer J, Bucher P, Spinas G, Donath M . Monounsaturated fatty acids prevent the deleterious effects of palmitate and high glucose on human pancreatic beta-cell turnover and function. Diabetes. 2003; 52(3):726-33. DOI: 10.2337/diabetes.52.3.726. View

Maedler K, Spinas G, Dyntar D, Moritz W, Kaiser N, Donath M . Distinct effects of saturated and monounsaturated fatty acids on beta-cell turnover and function. Diabetes. 2001; 50(1):69-76. DOI: 10.2337/diabetes.50.1.69. View

10.

Cai D, Yuan M, Frantz D, Melendez P, Hansen L, Lee J . Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med. 2005; 11(2):183-90. PMC: 1440292. DOI: 10.1038/nm1166. View

11.

Fleischman A, Shoelson S, Bernier R, Goldfine A . Salsalate improves glycemia and inflammatory parameters in obese young adults. Diabetes Care. 2007; 31(2):289-94. PMC: 3226794. DOI: 10.2337/dc07-1338. View

12.

Boni-Schnetzler M, Boller S, Debray S, Bouzakri K, Meier D, Prazak R . Free fatty acids induce a proinflammatory response in islets via the abundantly expressed interleukin-1 receptor I. Endocrinology. 2009; 150(12):5218-29. DOI: 10.1210/en.2009-0543. View

13.

Jiao P, Chen Q, Shah S, Du J, Tao B, Tzameli I . Obesity-related upregulation of monocyte chemotactic factors in adipocytes: involvement of nuclear factor-kappaB and c-Jun NH2-terminal kinase pathways. Diabetes. 2008; 58(1):104-15. PMC: 2606857. DOI: 10.2337/db07-1344. View

14.

van de Veerdonk F, Smeekens S, Joosten L, Kullberg B, Dinarello C, van der Meer J . Reactive oxygen species-independent activation of the IL-1beta inflammasome in cells from patients with chronic granulomatous disease. Proc Natl Acad Sci U S A. 2010; 107(7):3030-3. PMC: 2840365. DOI: 10.1073/pnas.0914795107. View

15.

Murdoch C, Muthana M, Lewis C . Hypoxia regulates macrophage functions in inflammation. J Immunol. 2005; 175(10):6257-63. DOI: 10.4049/jimmunol.175.10.6257. View

16.

Nathan D, Buse J, Davidson M, Ferrannini E, Holman R, Sherwin R . Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2008; 32(1):193-203. PMC: 2606813. DOI: 10.2337/dc08-9025. View

17.

Unger R . Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. Diabetes. 1995; 44(8):863-70. DOI: 10.2337/diab.44.8.863. View

18.

Hotamisligil G . Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell. 2010; 140(6):900-17. PMC: 2887297. DOI: 10.1016/j.cell.2010.02.034. View

19.

Cai D, Frantz J, Tawa Jr N, Melendez P, Oh B, Lidov H . IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell. 2004; 119(2):285-98. DOI: 10.1016/j.cell.2004.09.027. View

20.

Haversen L, Danielsson K, Fogelstrand L, Wiklund O . Induction of proinflammatory cytokines by long-chain saturated fatty acids in human macrophages. Atherosclerosis. 2008; 202(2):382-93. DOI: 10.1016/j.atherosclerosis.2008.05.033. View